之前在关注名单里排第二 Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Clinical Trial of Bexotegrast in Patients with Primary Sclerosing Cholan…
Pliant Therapeutics Reports Positive Results of Phase 1b Clinical Study Supporting Advancement of PLN-74809 for Treatment of Idiopathic Pulmonary Fibrosis译:姚佳思 校:曹文东本文来自罕见病信息网团队。欢迎转发分享;媒体、网站等平台如需转载,须注明来源。如有其他合作需求,请发送邮件至:info@cord.org.cn。